Phase I/II study of paclitaxel and radiotherapy in non-small cell lung cancer

Seminars in Oncology

Volumn 23, Issue 6 SUPPL. 16, 1996, Pages 124-127

  Marangolo, M ^a   Emiliani, E ^a   Rosti, G ^a   Giannini, M ^a   Vertogen, B ^a   Zumaglini, F ^a  

^a GENERAL HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RADIOSENSITIZING AGENT;

ADULT; AGED; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFICACY; DRUG RESPONSE; DRUG SCREENING; ESOPHAGITIS; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; NEUROLOGIC DISEASE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, NON-SMALL-CELL LUNG; DRUG ADMINISTRATION SCHEDULE; DRUG TOLERANCE; ESOPHAGITIS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LEUKOPENIA; LUNG NEOPLASMS; MALE; MIDDLE AGED; PACLITAXEL; PERIPHERAL NERVOUS SYSTEM DISEASES; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY; RADIOTHERAPY DOSAGE;

EID: 0030446316     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (7)